Fractyl Health (GUTS) Cash from Operations (2023 - 2026)

Fractyl Health (GUTS) has reported Cash from Operations for 4 consecutive years, with -$15.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations rose 24.99% year-over-year to -$15.9 million; the trailing twelve-month figure through Jun 2026 stood at -$82.4 million (down 1.32% YoY), and the FY2025 full-year result was -$90.3 million, down 37.86% from the prior year.
• Cash from Operations was -$15.9 million for Q2 2026 at Fractyl Health, up from -$22.5 million in the prior quarter.
• The five-year high for Cash from Operations was -$9.5 million in Q1 2023, with the low at -$25.1 million in Q1 2025.
• Historically, Cash from Operations has averaged -$16.9 million across 4 years, with a median of -$17.5 million in 2024.
• Annual changes were most pronounced in 2025 — Cash from Operations sank 114.15% — and 2026, when it climbed 24.99%.
• Tracing GUTS's Cash from Operations over 4 years: stood at -$10.6 million in 2023, then plunged by 60.71% to -$17.0 million in 2024, then retreated by 25.26% to -$21.3 million in 2025, then climbed by 25.47% to -$15.9 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$15.9 million in Q2 2026, -$22.5 million in Q1 2026, and -$21.3 million in Q4 2025.